Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.250
+0.100 (3.17%)
Jan 23, 2025, 12:31 PM EST - Market open
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending September 30, 2024, down -96.64% year-over-year. In the year 2023, Genelux had annual revenue of $170.00K, down -98.46%.
Revenue (ttm)
$8.00K
Revenue Growth
-96.64%
P/S Ratio
n/a
Revenue / Employee
$348
Employees
23
Market Cap
110.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
Dec 31, 2022 | 11.07M | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
GNLX News
- 5 weeks ago - Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - GlobeNewsWire
- 2 months ago - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point - Seeking Alpha
- 3 months ago - Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - GlobeNewsWire
- 3 months ago - Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 5 months ago - Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 5 months ago - Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - GlobeNewsWire
- 6 months ago - Genelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2024 - GlobeNewsWire